BioRestorative Therapies Inc (BRTX)

[I-Glow]

What? - "Every day will add value to the company, converting the warrants will add more value than the diluting happening so stop scaring people."

That is too funny - so the latest storyline is that massive dilution adds value to the company. SMH!

The company does indeed have debt - the Auctus debt etc. Saying the company doesn't have debt is absurd.

I love the Nasdaq pinkyland fantasy - why don't you read the listing requirements - and there is a huge problem that Nasdaq has with companies that use toxic financing - they don't get listed.

Plus, it appears that investors are clueless about the cost of Phase 2 and Phase 3 FDA approved clinical trials. That will cost a minimum of $50 million and another $50 million to bring a drug to market.

But the best is that dilution is a good thing.

IG